Astec-LifeSciences (5)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE admits privately placed commercial papers and debentures from various companies including ICICI Securities, IIFL Finance, Tata Projects, … | |||||||||||||||
NSE admits privately placed commercial papers and debentures from various companies including ICICI Securities, IIFL Finance, Tata Projects, and Toyota Financial Services to trading on the debt market segment effective December 19, 2025.
| |||||||||||||||
BSE revises price bands for 15 scrips including Tata Motors Ltd (to 20%), Allcargo Logistics Ltd (to 20%), and others with varying bands … | |||||||||||||||
BSE revises price bands for 15 scrips including Tata Motors Ltd (to 20%), Allcargo Logistics Ltd (to 20%), and others with varying bands from 2% to 20% effective November 26, 2025.
| |||||||||||||||
NSE announces listing of various commercial papers from multiple companies including ICICI Securities, Godrej Industries, Piramal Finance, … | |||||||||||||||
NSE announces listing of various commercial papers from multiple companies including ICICI Securities, Godrej Industries, Piramal Finance, and others on the debt market segment effective October 31, 2025.
| |||||||||||||||
NSE announces listing of 2,669,951 equity shares of Astec LifeSciences Limited allotted under Rights Issue, effective July 31, 2025. | |||||||||||||||
NSE announces listing of 2,669,951 equity shares of Astec LifeSciences Limited allotted under Rights Issue, effective July 31, 2025.
| |||||||||||||||
BSE lists 26,69,951 new equity shares of Astec Lifesciences Limited issued on rights basis, effective July 31, 2025. | |||||||||||||||
BSE lists 26,69,951 new equity shares of Astec Lifesciences Limited issued on rights basis, effective July 31, 2025.
| |||||||||||||||